Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model

A. Okal, K. J. Matissek, S. J. Matissek, R. Price, M. E. Salama, M. M. Janát-Amsbury, C. S. Lim

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model'. Together they form a unique fingerprint.

Medicine & Life Sciences